Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 5 (2008), Issue 3 (March)

1. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
   Cancer, 112(5): 1037-42. [Abstract] [Full-text]
2. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
   JAMA, 299(9): 1019-26. [Abstract] [Full-text]
3. Pancreatic neuroendocrine tumours.
   Eur J Surg Oncol, 34(3): 324-32. [Abstract] [Full-text]
4. Neoadjuvant and adjuvant strategies for pancreatic cancer.
   Eur J Surg Oncol, 34(3): 297-305. [Abstract] [Full-text]
5. Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy.
   Br J Surg, 95(4): 453-9. [Abstract] [Full-text]
6. Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms.
   Mol Cell Biol, 28(7): 2414-25. [Abstract] [Full-text]
7. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?
   Ann Surg Oncol, 15(4): 1161-8. [Abstract] [Full-text]
8. Color Doppler imaging predicts portal invasion by pancreatic adenocarcinoma.
   Ann Surg Oncol, 15(4): 1137-46. [Abstract] [Full-text]
9. Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model.
   Gut, 57(4): 483-91. [Abstract] [Full-text]
10. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01).
    Jpn J Clin Oncol, 38(3): 227-9. [Abstract] [Full-text]
11. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
    Cancer Res, 68(6): 1970-8. [Abstract] [Full-text]
12. Extra-gastrointestinal stromal tumor of the pancreas: case report and a review of the literature.
    Arch Surg, 143(3): 305-8. [Abstract] [Full-text]
13. Treatment decision making in pancreatic adenocarcinoma: multidisciplinary team discussion with multidetector-row computed tomography.
    Arch Surg, 143(3): 275-80; discussion 281. [Abstract] [Full-text]
14. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    J Clin Oncol, 26(9): 1489-95. [Abstract] [Full-text]
15. Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis.
    Proc Natl Acad Sci U S A, 105(11): 4306-11. [Abstract] [Full-text]
16. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.
    Oncogene, 27(13): 1951-60. [Abstract] [Full-text]
17. Activation of the alpha2beta1 integrin-mediated malignant phenotype on type I collagen in pancreatic cancer cells by shifts in the concentrations of extracellular Mg2+ and Ca2+.
    Int J Cancer, 122(10): 2199-209. [Abstract] [Full-text]
18. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
    Int J Cancer, 122(10): 2301-9. [Abstract] [Full-text]
19. Optimization of conditionally replicative adenovirus for pancreatic cancer and its evaluation in an orthotopic murine xenograft model.
    Am J Surg, 195(4): 481-90. [Abstract] [Full-text]
20. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
    Pancreas, 36(3): 309-13. [Abstract] [Full-text]
21. Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.
    Pancreas, 36(3): 241-8. [Abstract] [Full-text]
22. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
    Pancreas, 36(3): 236-40. [Abstract] [Full-text]
23. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
    Pancreas, 36(3): 225-35. [Abstract] [Full-text]
24. Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer.
    Pancreas, 36(3): e16-21. [Abstract] [Full-text]
25. Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation.
    Pancreas, 36(3): e1-9. [Abstract] [Full-text]
26. IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour.
    ANZ J Surg, 78(4): 252-6. [Abstract] [Full-text]
27. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    ANZ J Surg, 78(4): 245-51. [Abstract] [Full-text]
28. Strategy to reduce the risk of positive pancreatic resection margin at pancreatico-duodenectomy.
    ANZ J Surg, 78(4): 237-9. [Abstract] [Full-text]
29. Surgical management of carcinoma of the head of pancreas: extended lymphadenectomy or modified en bloc resection?
    ANZ J Surg, 78(4): 228-36. [Abstract] [Full-text]
30. Cystic neoplasms of the exocrine pancreas.
    Histopathology, 52(5): 539-51. [Abstract] [Full-text]
31. Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.
    Oncology, 73(1): 41-51. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.